Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Inhibition of Dexamethasone-induced Fatty Liver Development by Reducing miR-17-5p Levels
7-[4-(2-Piperidinyl)ethoxy]benzoyl Raloxifene is binding to the domain (LBD) of LRH-1
samples treated with AX15836 shows very few genes to be differentially expressed
extracted from patent WO2015104688 (example 1)
Smiles: OC1=CC2=C3C4=CC=C(O)C(O)=C4OCC3(O)CC2=CC1=O
TT-OAD2 free base cladesine calcium salt Inhibition of Dexamethasone-induced Fatty LiverTT OAD2 free base is a non peptide glucagon like peptide 1 (GLP 1) receptor agonist with an EC50 of 5 nM. TT OAD2 free base has the potential for diabetes treatment. Product information CAS Number: 1246826 07 2 Molecular Weight: 856. 83 Formula: C50H47Cl2N3O6 Chemical Name: (2S) 2 {[(3S,8S) 3 {4 [(3,4 dichlorophenyl)methoxy]phenyl} 7 [(1S) 1 phenylpropyl] 2H,3H,6H,7H,8H,9H [1,4]dioxino[2,3 g]isoquinolin 8 yl]formamido} 3 [4 (2,3 dimethylpyridin 4
US$ 535.00
US$ 535.00
US$ 749.00
US$ 1070.00